Researchers measured discordance between patient or family and physician global activity scores in juvenile dermatomyositis, and determined factors associated with discordance.
Muscle disease is more prominent among patients with dermatomyositis and anti-Mi2 autoantibodies compared with in those who have anti-Mi2-negative dermatomyositis.
Researchers studied the role of individual determinants of ultraviolet radiation exposure prior to dermatomyositis diagnosis.
Jemima Albayda, MD, discusses the cardiac complications in idiopathic inflammatory myopathies.
Investigators sought to determine whether patients with cutaneous lupus erythematosus have a similar frequency of antimalarial adverse cutaneous drug eruptions to patients with dermatomyositis.
One-third of patients with refractory anti-HMGCR antibodies had improved strength or other evidence of improved disease activity after rituximab treatment.
The signs and symptoms associated with disease activity in juvenile dermatomyositis could be used to stratify patients and adapt treatment plans.
Statin exposure was significantly associated with histologically confirmed idiopathic inflammatory myositis.
Low nailfold capillary density is associated with impaired pulmonary function tests and more frequent high-resolution computed tomography abnormalities in patients with juvenile dermatomyositis.
The JDM Image Score may have the potential to serve as a reliable biomarker of disease severity and response to therapeutic interventions in children with juvenile dermatomyositis.